Aldehyde groups on bioprosthetic tissue (None)

Aldehyde groups on bioprosthetic tissue are reactive chemical moieties primarily introduced during the glutaraldehyde cross-linking process used to stabilize biological scaffolds, such as porcine heart valves or bovine pericardium [1, 4]. While glutaraldehyde is essential for providing structural stability and reducing the immunogenicity of xenogeneic tissues, the remaining free or residual aldehyde groups serve as primary sites for dystrophic calcification [3, 10]. These groups possess a negative surface charge that attracts positively charged calcium ions from host plasma, initiating the formation of hydroxyapatite crystals that eventually lead to structural valve degeneration (SVD) [1, 6]. Consequently, these aldehyde groups are a major therapeutic target for anti-calcification treatments in the medical device industry [12, 16]. Various pharmacological and chemical strategies, including the use of amino acids, alcohols, and bisphosphonates, are employed to neutralize or "cap" these reactive sites to extend the functional lifespan of bioprosthetic implants [8, 13]. Modern technologies like RESILIA and ThermaFix specifically target these groups to minimize calcification and improve patient outcomes [10, 12].

Other names

Residual glutaraldehyde groupsFree aldehyde groupsGlutaraldehyde-derived aldehydesAldehyde residualsReactive aldehyde moieties

Chemical neutralization, capping, or reduction of reactive aldehyde groups to inhibit calcium ion binding and prevent the initiation of hydroxyapatite crystal formation.